ABT-501

N/A

Report date: 2025/02/20 11:50:07
NME

Base Information

Drug NameABT-501
Drug Alias NameABT-501
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionGonadotropin-releasing hormone receptor modulatorsTubulin inhibitorsTubulin polymerisation inhibitors
TargetsGonadotropin-releasing hormone receptorTubulin
Therapy Area/IndicationsOvarian NeoplasmsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnbogen Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAnbogen Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A